About Us

Premier ACO Physicians Network, LLC
Previous Names: N/A
ATTN: Value Based Programs
14201 Dallas Parkway
Dallas, TX 75254

ACO Primary Contact

Primary Contact Name Rodney Farrar
Primary Contact Phone Number (469) 893-2730
Primary Contact Email Address PremierACO@tenethealth.com

Organizational Information

ACO Participants:

ACO Participants ACO Participant in Joint Venture
Ajay G. Meka, M.D., Inc. N
Alicia G Nugas, M.D., Inc. N
Dr. Linda Hsu, A Professional Corp. N
Good Life Medical Group, Inc. N
Harold W. Seifer, M.D. & Michael Freund, M.D., Inc. N
Joseph Au, M.D. N
Julie Sherman N
Loan T Truong, M.D., Inc N
Loida P Constantino, M.D. Inc N
Prohealth Partners, A Medical Group N
Reginald Yeske, M.D. N
Robby T Ayoub, M.D. Prof Medical Corp N
Robert Melikian, M.D. N
Srividya Venkataraman, M.D., Inc. N
St John Medical Group, Inc N
Wellcare Medical Group N

ACO Governing Body:

Member
Last Name		 Member
First Name		 Member
Title/Position		 Member's Voting Power: expressed as a percentage or number Membership Type ACO Participant Legal Business Name/DBA, if applicable
Shah Mansoor Board Chair 8.33% ACO Participant Rep ProHealth Partners
Saeed Khalid Phys Board Member 8.33% ACO Participant Rep ProHealth Partners
DeJong Clayton Phys Board Member 8.33% ACO Participant Rep ProHealth Partners
Allswang Barry Phys Board Member 8.33% ACO Participant Rep ProHealth Partners
Yeske Reginald Phys Board Member 8.33% ACO Participant Rep Reginal Yeske, MD
Licuanan Jessee Phys Board Member 8.33% ACO Participant Rep ProHealth Partners
Chung Winston Phys Board Member 8.33% ACO Participant Rep ProHealth Partners
Ayoub Robby Phys Board Member 8.33% ACO Participant Rep Robby T Ayoub MD Prof Medical Corp
Hugh Peter Phys Board Member 8.33% ACO Participant Rep Good Life Medical Group, Inc
Venkataraman Srividiya Phys Board Member 8.33% ACO Participant Rep Srividiya Venkataraman, MD, Inc
Maison Beverly Board Member 8.33% Facility Participant Rep N/A
Soni Viney Board Member 8.33% Medicare Beneficiary N/A
Constanza Donna Community Stakeholder 0% Facility Participant Rep N/A
Boullon Rob Community Stakeholder 0% ACO Participant Rep ProHealth Partners

Key ACO clinical and administrative leadership:

  • ACO Executive: Rodney Farrar
  • Medical Director: Khalid Saeed
  • Compliance Officer: Stephanie Carpenter
  • Quality Assurance/Improvement Officer: Rodney Farrar

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
N/A N/A

 

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses:

  • Third Agreement Period
    • Performance Year 2020, $2,607,236
    • Performance Year 2019, $1,031,362
  • Second Agreement Period
    • Performance Year 2019, $1,031,362
    • Performance Year 2018, $2,642,280
    • Performance Year 2017, $0
    • Performance Year 2016, $0
  • First Agreement Period
    • Performance Year 2015, $0
    • Performance Year 2014, $0
    • Performance Year 2013, $0

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Shared Savings Distribution:

  • Third Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: 25%
      • Proportion invested in redesigned care processes/resources: 25%
      • Proportion of distribution to ACO participants: 50%
    • Performance Year 2019
      • Proportion invested in infrastructure: 25%
      • Proportion invested in redesigned care processes/resources: 25%
      • Proportion of distribution to ACO participants: 50%
    • Second Agreement Period
      • Performance Year 2019
        • Proportion invested in infrastructure: 25%
        • Proportion invested in redesigned care processes/resources: 25%
        • Proportion of distribution to ACO participants: 50%
      • Performance Year 2018
        • Proportion invested in infrastructure: 25%
        • Proportion invested in redesigned care processes/resources: 25%
        • Proportion of distribution to ACO participants: 50%
      • Performance Year 2017
        • Proportion invested in infrastructure: N/A
        • Proportion invested in redesigned care processes/resources: N/A
        • Proportion of distribution to ACO participants: N/A
      • Performance Year 2016
        • Proportion invested in infrastructure: N/A
        • Proportion invested in redesigned care processes/resources N/A
        • Proportion of distribution to ACO participants: N/A
      • First Agreement Period
        • Performance Year 2015
          • Proportion invested in infrastructure: N/A
          • Proportion invested in redesigned care processes/resources N/A
          • Proportion of distribution to ACO participants: N/A
        • Performance Year 2014
          • Proportion invested in infrastructure: N/A
          • Proportion invested in redesigned care processes/resources N/A
          • Proportion of distribution to ACO participants: N/A
        • Performance Year 2013
          • Proportion invested in infrastructure: N/A
          • Proportion invested in redesigned care processes/resources N/A
          • Proportion of distribution to ACO participants: N/A

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Quality Performance Results

2020 Quality Performance Results:

ACO # Measure Name Rate ACO Mean
ACO8 Risk-Standardized,All Condition Readmission 15.54 15.07
ACO38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 48.23 49.50
ACO43 Ambulatory Sensitive Condition Acute Composite 0.61 0.95
ACO13 Falls: Screening for Future Fall Risk 57.71 84.97
ACO14 Preventive Care and Screening: Influenza Immunization 54.39 76.03
ACO17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 75.00 81.67
ACO18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 46.37 71.46
ACO19 Colorectal Cancer Screening 67.85 72.59
ACO20 Breast Cancer Screening 73.32 74.05
ACO42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 74.96 83.37
ACO27 Diabetes: Hemoglobin A1c Poor Control (>9%) 19.31 14.70
ACO28 Controlling High Blood Pressure 71.97 72.87

* Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

  • Waiver for Payment for Telehealth Services:
    • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.